Applied immunohistochemistry & molecular morphology : AIMM · 2010
Immunohistochemical study as a tool in differential diagnosis of pediatric malignant rhabdoid tumor.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Machado Isidro, Noguera Rosa, Santonja Nuria, Donat Joaquín, Fernandez-Delgado Rafael, Acevedo Agustín, Baragaño Marta, Navarro Samuel
Аннотация
Malignant rhabdoid tumors (MRTs) are aggressive childhood neoplasms, occurring mainly in the kidney and brain. We describe 2 unusual cases of extrarenal and noncranial location (liver and soft tissue with dissemination) mimicking hepatoblastoma, neuroblastoma or Ewing sarcoma. Both cases revealed a polyphenotypic profile, combined with cytokeratin, vimentin, and CD99 expression. INI1/BAF-47 showed negative protein nuclear expression in both cases, suggesting a diagnosis of MRT. An extensive immunohistochemical panel was performed to exclude pediatric tumors reminiscent of MRT. The genetic studies failed to detected MYCN amplification, 11q23 deletion, and EWS break-apart positivity. No alterations of 22q integrity were demonstrated with the probes used for the study (N25 Di George/22q11.2, 22qter, and EWS/22q12). We discuss the differential diagnosis in pediatric polyphenotypic tumors (Wilms tumor, neuroblastoma, desmoplastic small round cell tumor, and Ewing sarcoma). Analysis of INI1/BAF-47 expression can offer important clues in the diagnosis of pediatric tumors with rhabdoid phenotype. The integration of clinical, morphologic, immunohistochemical, and genetic data is required to approach a correct diagnosis of pediatric tumor in unusual location with atypical or undifferentiated morphology.
Предметные рубрики MeSH
12E7 AntigenAntigens, CDAntineoplastic Combined Chemotherapy ProtocolsCell Adhesion MoleculesChromosomal Proteins, Non-HistoneChromosome AberrationsDNA-Binding ProteinsDiagnosis, DifferentialDrug Resistance, NeoplasmFatal OutcomeFemaleHumansImmunohistochemistryInfantInfant, NewbornKeratinsLiver NeoplasmsN-Myc Proto-Oncogene ProteinNeoplasms, Multiple PrimaryNuclear ProteinsOncogene ProteinsRNA-Binding Protein EWSRhabdoid TumorSMARCB1 ProteinSkin NeoplasmsTranscription FactorsVimentin